Published in Res Commun Chem Pathol Pharmacol on August 01, 1984
Quantification of Coomassie Blue stained proteins in polyacrylamide gels based on analyses of eluted dye. Anal Biochem (1975) 3.35
Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol (1982) 1.87
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol (1983) 1.36
The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res (1979) 1.31
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol (1975) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Myocardial cation contents during induction of calcium paradox. Am J Physiol (1979) 1.11
A new cardiac myosin characterized from the canine atria. Biochem Biophys Res Commun (1977) 1.10
Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol (1999) 1.07
Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol Rev (1999) 1.07
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Calmidazolium and compound 48/80 inhibit calmodulin-dependent protein phosphorylation and ATP-dependent Ca2+ uptake but not Ca2+-ATPase activity in skeletal muscle sarcoplasmic reticulum. J Biol Chem (1984) 1.04
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes (2001) 1.04
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation. J Mol Cell Cardiol (1998) 1.02
Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol (1983) 1.01
Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol (1989) 0.99
Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res (2000) 0.98
Modification of a discontinuous and highly porous sodium dodecyl sulfate-polyacrylamide gel system for minigel electrophoresis. Anal Biochem (1990) 0.98
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther (1999) 0.98
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A (1983) 0.98
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
Alterations in cardiac membrane Ca2+ transport during oxidative stress. Mol Cell Biochem (1990) 0.97
Alternative splicing in intracellular loop connecting domains II and III of the alpha 1 subunit of Cav1.2 Ca2+ channels predicts two-domain polypeptides with unique C-terminal tails. J Biol Chem (2001) 0.97
Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol (1972) 0.97
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg (2001) 0.96
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem (2000) 0.96
Myosin chains of myocardial tissue. I. Purification and immunological properties of myosin heavy chains. Biochem Biophys Res Commun (1973) 0.95
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol (1975) 0.95
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J (1992) 0.94
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J (1981) 0.94
Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol (1981) 0.94
Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol (1985) 0.94
Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. Mol Pharmacol (1970) 0.93
Studies on the synthesis and degradation of light and heavy chains of cardiac myosin. J Biol Chem (1973) 0.93
Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol (1983) 0.93
Role of extracellular matrix proteins in heart function. Mol Cell Biochem (1993) 0.93
The cardiac cycle: regulation and energy oscillations. Am J Physiol (1983) 0.93
Identification of low molecular weight GTP-binding proteins and their sites of interaction in subcellular fractions from skeletal muscle. J Biol Chem (1991) 0.93
Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem (1997) 0.93
Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol (1987) 0.93
Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol (1975) 0.92
Subcellular distribution of dystrophin in isolated adult and neonatal cardiac myocytes. Am J Physiol (1994) 0.92
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
Myocardial cell damage during experimental infective endocarditis. Lab Invest (1975) 0.91
Excitation-contraction coupling in heart. VI. Demonstration of calcium activated ATPase in the dog heart sarcolemma. Life Sci I (1971) 0.91
Molecular cloning, expression, and chromosomal assignment of sarcolemmal-associated proteins. A family of acidic amphipathic alpha-helical proteins associated with the membrane. J Biol Chem (1997) 0.91
Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta (1996) 0.91
Comparative analyses of the kinetics and subunits of myosins from canine skeletal muscle and cardiac tissue. J Biol Chem (1975) 0.91
Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol (1977) 0.91
Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol (1992) 0.90
Oscillations of intramuscular pH in perfused rat heart. Can J Physiol Pharmacol (1973) 0.90
Alternative splicing, expression, and genomic structure of the 3' region of the gene encoding the sarcolemmal-associated proteins (SLAPs) defines a novel class of coiled-coil tail-anchored membrane proteins. J Biol Chem (2000) 0.90
Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol (1999) 0.90
Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol (1994) 0.89
Paradoxical role of lipid metabolism in heart function and dysfunction. Mol Cell Biochem (1992) 0.89
Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther (1998) 0.89
Subcellular calcium transport in failing hearts due to calcium deficiency and overload. Am J Physiol (1976) 0.89
Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim Biophys Acta (1991) 0.89
Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol (1992) 0.89
Quantification of the minimal luminal cross-sectional area after coronary stenting by two- and three-dimensional intravascular ultrasound versus edge detection and videodensitometry. Am J Cardiol (1996) 0.88
Characterization of insulin receptors in cardiac sarcolemmal and sarcoplasmic reticular membranes. J Cardiovasc Pharmacol (1987) 0.88
Abnormalities in heart membranes and myofibrils during bacterial infective cardiomyopathy in the rabbit. Circ Res (1976) 0.88
Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am J Physiol (1989) 0.88
Changes in cAMP concentrations during chronic cardiac hypertrophy. Basic Res Cardiol (1979) 0.88
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J Mol Cell Cardiol (1976) 0.88
Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy. Circ Res (1986) 0.88
Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des (2009) 0.88
Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys (2001) 0.88
Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem (1998) 0.87
Formation of gigantic mitochondria in hypoxic isolated perfused rat hearts. Experientia (1969) 0.87
Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol (1985) 0.86
Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res (1990) 0.86
Isolation of skeletal muscle membrane fragments containing active Na+-K+ stimulated ATPase: comparison of normal and dystrophic muscle sarcolemma. Biochem Biophys Res Commun (1971) 0.86
Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes. J Mol Cell Cardiol (1999) 0.86
The effect of progesterone on biosynthetic pathways in mammary tissue. Endocrinology (1972) 0.86
Dissociation and reassociation of rabbit skeletal muscle myosin. Biochimie (1979) 0.86
Influence of reducing agents on adrenochrome-induced changes in the heart. Arch Pathol Lab Med (1981) 0.86
Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem (1995) 0.86
Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies. Lab Invest (1981) 0.86
Neuropeptide Y modulation of sympathetic activity in myocardial infarction. J Am Coll Cardiol (1996) 0.85
Responses of contractile function to ruthenium red in rat heart. Am J Physiol (1988) 0.85
Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J Pharmacol Exp Ther (2000) 0.85
Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J (1996) 0.85
Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats. Diabetes Res Clin Pract (1996) 0.85
Influence of fluothane on calcium accumulation by the heavy microsomal fraction of human skeletal muscle: comparison with a patient with malignant hyperpyrexia. Biochem Med (1972) 0.85